Free Trial
→ BREAKING: Trump Bans NVIDIA Chips to China (From Behind the Markets) (Ad) Buy NRXPW Stock  Free NRXPW Stock Alerts

NRx Pharmaceuticals (NRXPW) SEC Filings & 10K Form

$0.06 0.00 (-2.26%)
As of 04/17/2025 11:38 AM Eastern
Compare

Recent NRx Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
04/17/2025
4:22 PM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 424B3
04/17/2025
4:24 PM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
4:21 PM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
2:07 PM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
02/20/2025
9:57 AM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 424B3
02/03/2025
3:40 PM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2025
4:10 PM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2025
8:24 AM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 424B3
01/22/2025
3:32 PM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
3:12 PM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
7:32 AM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
7:27 AM		Javitt Jonathan C (Reporting)
NRX Pharmaceuticals, Inc. (Issuer)
NRx Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
12:44 PM		ABRAMS MICHAEL S (Reporting)
NRX Pharmaceuticals, Inc. (Issuer)
NRx Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/20/2024
8:00 AM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
4:24 PM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
11:21 AM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/31/2024
7:00 AM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
3:52 PM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
3:53 PM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:18 PM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form DEF 14A
08/20/2024
3:38 PM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
4:27 PM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
3:39 PM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
4:15 PM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
3:58 PM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
6:37 PM		McBride Dennis (Reporting)
NRX Pharmaceuticals, Inc. (Issuer)
NRx Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/20/2024
4:03 PM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
4:26 PM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
3:46 PM		NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
Form 10-K/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NRXPW) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners
The real reason gold is soaring (and likely to continue)
Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...
Golden Portfolio | Sponsored
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
The first casualty of the 2025 trade war
The headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...
Investors Alley | Sponsored
My prediction is coming true
We've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...
InvestorPlace | Sponsored
Musk’s AI Masterplan – Our #1 AI Stock to Buy Now
Did Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...
Behind the Markets | Sponsored
Read before the next tariff announcement
Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...
Brownstone Research | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
Crypto’s crashing…but we’re still profiting
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....
Crypto Swap Profits | Sponsored